中证智能财讯 中国资源交通（00269）7月31日披露2024-2025年年度报告。截至3月31日的12个月内，公司实现营业收入5.78亿港元，同比下降2.61%；归母 净利润亏损3.38亿港元，上年同期盈利17.32亿港元；经营活动产生的现金流量净额为1.87亿港元，同比下降82.12%；据报告显示，中国资源交通基本每股收 益为-0.03港元。 以7月31日收盘价计算，中国资源交通目前市净率（TTM）约-0.01倍，市销率（TTM）约0.2倍。 公司是主要从事高速公路、石油及木材相关业务的香港投资控股公司，通过三大分部运营：高速公路营运分部从事高速公路的营运、管理及维修以及配套设 施的投资；石油分部从事石油及相关产品贸易、提供石油储存及配套服务以及压缩天然气加气站营运；木材营运分部从事森林、植树区、树苗以及精炼茶油 的销售。 营收、净利同比增长率半年度变动情况(%) 400 - 200 0 +17,22 1132,32 05 8:42 9 1,5 626.83, 13.6,25.28 -7.5 ,3.29 -200 -400 -600 -800 -1,000 - -1-2022H2 J22-2023H2 2 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部份內容而產生或 因倚賴該等內容而引致之任何損失承擔任何責任。 股東週年大會通告 茲通告中國資源交通集團有限公司（「本公司」）謹訂於 2025 年 8 月 28 日（星期四）上 午十一時正假座中國廣東省深圳市福田區金田路榮超經貿中心 2408 室舉行股東週年大會 （「股東週年大會」），藉以考慮下列決議案： 作為普通事項 A. 考慮及酌情通過下列決議案（ 考慮及酌情通過下列決議案（不論有否經修訂 不論有否經修訂 不論有否經修訂）作為普通決議案 作為普通決議案: 「動議︰ CHINA RESOURCES AND TRANSPORTATION GROUP LIMITED 中國資源交通集團有限公司 （於開曼群島註冊成立之有限公司） （股份代號︰269） 作為特別事項 1. 省覽及考慮截至 2025 年 3 月 31 日止年度之經審核財務報表及本公司董事 （「董事」）會與核數師報告書。 2. 重選段景泉先生為執行董事，以及井寶利先生與包良明先生為獨立非執行董事。 3. 授權董 ...

此 乃 要 件 請 即 處 理 閣下如 對本通函任何方面或應採取之行動有任何疑問，應諮詢股票經紀、銀行經 理、律師、專業會計師或其他專業顧問。 閣下如已將名 下 之 中國資源交通集團有限公司股 份全 部 售出或轉讓，應立即將本 通函連同隨附之代表委任表格送交買主或承讓人，或經手買賣或轉讓之銀行、股 票經紀或其他代理商，以便轉交買主或承讓人。 香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 通 函 之 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本通函全部 或 任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 CHINA RESOURCES AND TRANSPORTATION GROUP LIMITED 中國資源交通集團有限公司 （於開曼群島註冊成立之有限公司） （股份代號：269） (1) 建議授出發行新股份 及購回股份之一般授權 及購回股份之一般授權 購回股份之一般授權； (2) 建議重選董事； 建議重選董事； 及 (3) 股東週年大會通告 股東週年大會通告 本 公 司 謹 訂 於 2025年8月2 ...

（於開曼群島註冊成立之有限公司） ANNUAL REPORT 2025 年報 ANNUAL REPORT 2025 AUDIT COMMITTEE 年報 Contents 目錄 | CORPORATE INFORMATION | | CONSOLIDATED STATEMENT OF PROFIT OR | | | --- | --- | --- | --- | | 公司資料 | 2 | LOSS AND OTHER COMPREHENSIVE INCOME | | | | | 綜合損益及其他全面收益表 | 95 | | STATEMENT OF CHAIRMAN | | | | | 主席報告書 | 4 | CONSOLIDATED STATEMENT OF | | | | | FINANCIAL POSITION | | | MANAGEMENT DISCUSSION AND ANALYSIS | | 綜合財務狀況表 | 97 | | 管理層討論及分析 | 5 | | | | | | CONSOLIDATED STATEMENT OF | | | DIRECTORS' REPORT | | CHANGES ...

*ST双成(002693.SZ)发布2025年半年度报告，该公司营业收入为8412.21万元，同比减少11.35%。归属 于上市公司股东的净亏损为1846.66万元，同比扩大8.97%。归属于上市公司股东的扣除非经常性损益的 净亏损为2101.58万元，同比扩大18.34%。基本每股亏损为0.0445元。 ...

Group 1 - The stock price of *ST Shuangcheng (002693) closed at 7.73 yuan, an increase of 5.03% as of July 3, 2025, with a turnover rate of 3.04% and a trading volume of 125,000 hands, amounting to 94.8451 million yuan [1] - The net inflow of main funds today was 36.1462 million yuan, accounting for 38.11% of the transaction amount, with large orders contributing 19.0871 million yuan (20.12%) and 17.0592 million yuan (17.99%) respectively [1] - The latest quarterly report shows total operating revenue of 36.6758 million yuan, a year-on-year decrease of 14.23%, and a net profit attributable to shareholders of 10.0405 million yuan, down 14.84% year-on-year [1] Group 2 - Hainan Shuangcheng Pharmaceutical Co., Ltd. was established in 2000 and is primarily engaged in the pharmaceutical manufacturing industry, located in Haikou City [2] - The company has made investments in 2 enterprises, participated in 133 bidding projects, and holds 28 trademark registrations and 15 patents, along with 301 administrative licenses [2]

中國資源交通集團有限公司 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部份內容而產生或因倚賴該 等內容而引致之任何損失承擔任何責任。 CHINA RESOURCES AND TRANSPORTATION GROUP LIMITED （於開曼群島註冊成立之有限公司） （股份代號︰269） 截至2025年3月31日止年度之 全年業績公佈 中國資源交通集團有限公司（「本公司」）董事會（「董事會」）公佈本公司及其附屬公司（「本集 團」）截至2025年3月31日止年度之年度綜合業績，連同去年之比較數字如下： 1 綜合全面收益表 綜合全面收益表 截至2025年3月31日止年度 | | | 2025年 | 2024年 | | --- | --- | --- | --- | | | 附註 | 港幣千元 | 港幣千元 | | 收益 | 5 | 577,662 | 593,148 | | 銷售成本 | | (432,813) | (372,738) | | 毛利 | | 144,849 | 220,410 | | 其他收入及其他 ...

Core Points - *ST Shuangcheng (002693) reported a closing price of 8.22 yuan as of June 6, 2025, down 2.72% from the previous week [1] - The company achieved a market capitalization of 3.409 billion yuan, ranking 123rd out of 150 in the chemical pharmaceutical sector and 3924th out of 5148 in the A-share market [1] Company Announcements - *ST Shuangcheng's injectable paclitaxel (albumin-bound) ANDA received approval from the US FDA for market entry, and the company has received a total of 6 million USD in milestone payments [1] - The company signed a licensing and supply agreement, granting exclusive rights to Meitheal Pharmaceuticals, Inc. and Hong Kong King-Friend Industrial Co., Ltd. for the development and production of injectable paclitaxel (albumin-bound) (100mg/vial) in the US [1] - From October 2022 to April 2023, the company received 3 million USD in milestone payments from HKF, and in May 2025, the FDA approved the ANDA, leading to the first shipment to the US [1] - Recently, the company received the remaining 3 million USD in milestone payments, totaling 6 million USD, which will be recognized as deferred revenue according to accounting standards [1]

Financial Performance - For the six months ended September 30, 2024, the company reported an unaudited net loss attributable to shareholders of approximately HKD 109,833,000, compared to a net profit of approximately HKD 820,452,000 for the same period last year [4]. - The total comprehensive loss for the period was HKD 148,998,000, a significant decrease from a total comprehensive income of HKD 538,754,000 in the previous year [7]. - The gross profit for the period was HKD 101,355,000, compared to HKD 141,990,000 in the previous year, reflecting a decline of 28.5% [15]. - The company recorded a net loss of approximately HKD 106,915,000 for the six months ended September 30, 2024, compared to a profit of HKD 964,410,000 for the same period in 2023 [36][49]. - The group reported a net loss of HKD 106,915,000 for the period, contrasting with a profit of HKD 964,410,000 in the previous year [98]. - The company reported a total revenue of HKD 30,782,000 for the six months ended September 30, 2024, significantly down from HKD 1,104,311,000 in the previous year [49]. - The group recorded a debt restructuring gain of approximately HKD 992.70 million for the six months ended September 30, 2023, with no such gains recognized for the six months ended September 30, 2024 [192]. Revenue and Operations - Revenue from toll fees for highway operations was approximately HKD 300,003,000, down 7.5% from HKD 324,344,000 in the same period last year [13]. - For the six months ended September 30, 2024, the group recorded an unaudited EBITDA of approximately HKD 221,341,000, compared to HKD 280,695,000 for the same period in 2023, representing a decrease of about 21% [95]. - The company aims to stimulate traffic volume and toll revenue growth by adjusting its business strategy in a competitive market environment [120]. - The group has faced adverse impacts on operations due to extreme weather conditions, which have led to traffic disruptions and reduced toll revenue [120]. - The average daily toll revenue for the Zhunxing Expressway for the six months ended September 30, 2024, was RMB 1.51 million, down 6.79% from RMB 1.62 million in the same period last year [140]. - Toll revenue from highway operations was approximately HKD 300.00 million for the six months ended September 30, 2024, a decrease of about 7.50% compared to HKD 324.34 million for the same period last year [189]. Financial Position and Liabilities - Total assets as of September 30, 2024, were valued at HKD 6,324,506,000, a slight increase from HKD 6,300,592,000 in the previous year [18]. - The total liabilities amounted to HKD 19,345,488,000, compared to HKD 19,065,661,000 in the previous year, representing an increase of 1.5% [19]. - The company’s net debt position was approximately HKD 13,020.98 million, an increase from HKD 12,765.07 million as of March 31, 2024 [195]. - The debt ratio as of September 30, 2024, was approximately 305.88%, up from 302.60% as of March 31, 2024 [196]. - The company classified all outstanding borrowings as current liabilities due to a debt restructuring process, indicating a default status prior to completion [198]. - The total liabilities, including unpaid accrued default interest of approximately HKD 4,455.64 million, amounted to approximately HKD 18,400.09 million as of September 30, 2024 [200]. Cash Flow and Financing - Cash and cash equivalents decreased to HKD 10,768,000 as of September 30, 2024, from HKD 13,372,000 at the beginning of the period [35]. - The company has a total cash outflow from financing activities of HKD 173,275,000, which includes interest payments of HKD 96,351,000 [35]. - The company aims to raise new funds to ensure sufficient working capital for the next 12 months [39]. - The net cash generated from operating activities was HKD 173,932,000 for the six months ended September 30, 2024, compared to a cash outflow of HKD 5,678,000 in the previous year, indicating a significant improvement in cash flow [87]. - The group is seeking new financing channels to improve its liquidity and operational funding situation [106]. Management and Strategy - The company’s operational strategy includes independent management of its three reportable segments, each requiring different business strategies [44]. - The group has implemented a comprehensive road maintenance plan to ensure optimal road conditions, aiming to enhance traffic flow and toll revenue [120]. - The group aims to enhance daily management of the highway operations through comprehensive inspections to curb toll evasion and leakage [169]. - The group plans to implement a differentiated toll pricing strategy to attract various types of vehicles on the highway, based on national toll policies [186]. Dividends and Shareholder Returns - The company did not recommend any dividend distribution for the six months ended September 30, 2024, consistent with the previous year where no dividends were declared [56]. - The company did not declare any dividends for the six months ended September 30, 2024, consistent with the previous year where no dividends were declared [79]. Legal and Compliance - The group has not recognized any additional provisions related to a legal dispute involving a contractor, pending a final court decision [117].

Financial Performance - For the six months ended September 30, 2022, the unaudited revenue was approximately HKD 375,398,000, compared to HKD 195,967,000 for the same period last year, representing an increase of 91.5%[5]. - The unaudited EBITDA for the same period was approximately HKD 302,208,000, up from HKD 149,588,000 year-on-year, indicating a growth of 102.5%[5]. - The gross profit for the period was HKD 44,522,000, a significant recovery from a gross loss of HKD 219,690,000 in the same period last year[8]. - Revenue from toll road fees for the six months ended September 30, 2022, was HKD 373,738,000, compared to HKD 193,996,000 for the same period in 2021, representing an increase of approximately 92.5%[79]. - Total revenue for the group during the same period was HKD 375,398,000, up from HKD 195,967,000 in 2021, indicating a growth of approximately 91.5%[79]. - The reported loss before tax for the six months ended September 30, 2022, was HKD (501,706) thousand, an improvement from HKD (760,488) thousand in the same period of 2021, representing a reduction of approximately 34%[87]. - The net loss for the six months ended September 30, 2022, was approximately HKD 654.95 million, an increase of about 5.94% from HKD 618.24 million for the same period last year[187]. Loss and Liabilities - The unaudited net loss attributable to owners of the company for the six months was approximately HKD 583,408,000, compared to a loss of HKD 517,808,000 in the previous year, reflecting an increase in losses of 12.7%[5]. - The company reported a total comprehensive loss of HKD 654,950,000 for the period, compared to a loss of HKD 618,243,000 in the prior year[11]. - As of September 30, 2022, the total liabilities amounted to HKD 22,650,929 thousand, a decrease of 6% from HKD 24,107,404 thousand as of March 31, 2022[16]. - The group reported a net loss of approximately HKD 654,950,000 for the six months ended September 30, 2022[72]. - The group failed to repay approximately HKD 10,126,248,000 in bank loans and HKD 440,053,000 in other borrowings, along with HKD 4,395,648,000 in non-redeemable bonds[72]. - Total debts, including accrued default interest of approximately HKD 4,857,952,000, amounted to approximately HKD 19,819,901,000 classified as current liabilities[72]. - The total liabilities as of September 30, 2022, were HKD (16,388,221) thousand, compared to HKD (17,960,684) thousand as of March 31, 2022, indicating a decrease of approximately 9%[87]. - The company's total current liabilities were approximately HKD 21,525.14 million as of September 30, 2022, down from HKD 23,048.57 million as of March 31, 2022[197]. Cash Flow and Assets - The company’s cash and cash equivalents increased to HKD 53,962,000 from HKD 41,398,000, marking a growth of 30.4%[14]. - The net cash generated from operating activities was HKD 12,852 thousand, a significant improvement from a cash outflow of HKD (15,127) thousand in the previous year[70]. - Cash and cash equivalents at the end of the period increased to HKD 53,962 thousand from HKD 24,497 thousand, marking a growth of 120%[70]. - The total assets as of September 30, 2022, were valued at HKD 9,239,247,000, down from HKD 9,708,725,000 as of March 31, 2022[15]. - The total assets less current liabilities stood at HKD (13,291,314) thousand, a decrease of 6.7% from HKD (14,247,509) thousand[16]. - The group’s cash and bank balances as of September 30, 2022, were approximately HKD 53.96 million, compared to HKD 41.40 million as of March 31, 2022[191]. Debt Management and Restructuring - The board believes that if the proposed measures are successfully implemented, the group will have sufficient working capital to meet its financial obligations for the next 12 months[74]. - The group is actively negotiating debt restructuring and/or deferral of repayments with multiple banks and financial institutions in China[74]. - The management's ability to implement the proposed plans remains subject to significant uncertainty[74]. - The company is facing significant uncertainties regarding its ability to continue as a going concern due to its inability to repay certain borrowings[199]. - The board has implemented measures to improve the company's liquidity position, although these measures are not yet completed[200]. Operational Insights - The company has not announced any new product developments or market expansion strategies during this reporting period[5]. - The management plans to implement several measures to stimulate traffic volume and toll revenue growth on the Junxing Expressway, including a comprehensive road maintenance plan and enhanced vehicle inspection at toll stations[177]. - The company reported that the coal market experienced significant price volatility due to macroeconomic recovery and various external factors, impacting the overall traffic volume on the Junxing Expressway[172]. - The management noted that strict traffic controls and border restrictions due to the COVID-19 pandemic adversely affected traffic volume on the Junxing Expressway in 2022[175]. - The company has identified opportunities for collaboration with nearby logistics bases and coal chemical enterprises to expand its customer base and promote the advantages of the Junxing Expressway[177]. Employee and Management Costs - The total remuneration for key management personnel for the six months ended September 30, 2022, was HKD 120,000, significantly higher than HKD 30,000 in the same period last year[168]. - The company’s employee costs (excluding directors' remuneration) for the six months ended September 30, 2022, were HKD 30,004 thousand, slightly lower than HKD 31,798 thousand in the same period of 2021, a decrease of about 6%[92]. Trade Receivables and Impairment - Trade receivables increased to HKD 890,573,000 from HKD 786,886,000, showing a rise of 13.2%[14]. - The net value of trade receivables increased to HKD 890,573,000 as of September 30, 2022, up from HKD 786,886,000 as of March 31, 2022, representing an increase of approximately 13.2%[113]. - The overdue receivables over 90 days reached HKD 703,699,000, representing a 4.0% increase from HKD 676,533,000 in the previous period[121]. - The provision for impairment losses on trade receivables decreased to HKD 5,628,000 as of September 30, 2022, down from HKD 7,477,000 as of March 31, 2022, showing a reduction of approximately 24.7%[118]. Capital Expenditures and Commitments - The company has committed but unprovided capital expenditures for the acquisition of properties, plants, and equipment amounting to HKD 21,734 million as of September 30, 2022, down from HKD 24,160 million as of March 31, 2022[168]. - The company’s outstanding capital commitments are primarily due to expenditures on property, plant, and equipment[196]. - The company confirmed a contingent liability of RMB 603.80 million related to additional construction costs as of September 30, 2022, consistent with the previous reporting period[169].